Cointime

Verantos

company

About

Verantos is the market leader in high-validity real-world evidence at scale for life sciences.

  • 51 - 100

Highlights

Total Funding Amount
$1.42M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$224.79K
Industries
Artificial Intelligence,Health Care,Pharmaceutical
Founded date
Jan 1, 2013
Number Of Employee
51 - 100
Operating Status
Active

Verantos is the market leader in high-validity real-world evidence for life sciences. By incorporating robust clinical narrative data, artificial intelligence technology, and measured validity, Verantos is the first company to generate research-grade evidence at scale across all therapeutic areas. The Verantos Evidence Platform integrates heterogeneous real-world data sources and generates evidence with the accuracy necessary for market access, HEOR, medical affairs, and regulatory use.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.42M
Verantos has raised a total of $1.42M in funding over 2 rounds. Their latest funding was raised on Dec 20, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 20, 2020 Grant $1.19M 1 National Science Foundation — Detail
Jun 25, 2018 Grant $224.79K 1 National Science Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Verantos is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Cointime
İçerikler
Şirket.